ZELDIS JEROME B
SEC CIK 1433982 · EDGAR
BoughtSold
Most active insiders at PTCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | — | $25.99M |
| 2 | Pauwels Eric | Chief BUSINESS Off | — | $7.48M |
| 3 | SCHMERTZLER MICHAEL | Dir | — | $6.31M |
| 4 | Boulding Mark Elliott | EVP AND CLO | — | $5.96M |
| 5 | Reeve Emma | Dir | — | $4.23M |
| 6 | Klein Matthew B. | CEO, Dir | — | $4.22M |
| 7 | Jacobson Allan Steven | Dir | — | $2.91M |
| 8 | Utter Christine Marie | SVP, CAO | — | $1.94M |
| 9 | Okey Stephanie | Dir | — | $1.46M |
| 10 | Smith Mary L. | Dir | — | $1.43M |
| 17 | ZELDIS JEROME B | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +4,000 | 22.5K | +22% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +4,000 | 18.5K | +28% | $0 |
| DM | 2024-12-04 | 2024-12-02 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | M - OptEx | $40.93 | +24.0K | 26.5K | +960% | +$982.3K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | S - Sale+OE | $51.50 | -24.0K | 14.5K | -62% | -$1.24M |
| D | 2024-11-22 | 2024-11-20 | NXGL | NEXGEL, INC. | ZELDIS JEROME B | Dir | P - Purchase | $2.75 | +3,636 | 106.7K | +4% | +$9,999 |
| D | 2024-08-27 | 2024-08-23 | NXGL | NEXGEL, INC. | ZELDIS JEROME B | Dir | P - Purchase | $2.50 | +10.0K | 103.0K | +11% | +$25.0K |
| D | 2024-05-24 | 2024-05-22 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | S - Sale+OE | $38.24 | -20.0K | 14.5K | -58% | -$764.8K |
| D | 2024-05-24 | 2024-05-22 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | M - OptEx | $26.42 | +20.0K | 34.5K | +138% | +$528.4K |
| D | 2024-02-16 | 2024-02-15 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +4,000 | 14.5K | +38% | $0 |
| 2023-05-30 | 2023-05-26 | NXGL | NEXGEL, INC. | ZELDIS JEROME B | Dir | P - Purchase | $2.34 | +5,000 | 93.0K | +6% | +$11.7K | |
| D | 2023-01-09 | 2023-01-05 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +4,000 | 10.5K | +62% | $0 |
| 2022-03-28 | 2022-03-25 | NXGL | NEXGEL, INC. | ZELDIS JEROME B | Dir | P - Purchase | $1.89 | +5,300 | 88.0K | +6% | +$10.0K | |
| D | 2022-01-11 | 2022-01-07 | PTCT | PTC THERAPEUTICS, INC. | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +3,200 | 6,500 | +97% | $0 |
| D | 2022-01-03 | 2021-12-27 | NXGL | NEXGEL, INC. | ZELDIS JEROME B | Dir | P - Purchase | $5.49 | +9,091 | 82.7K | +12% | +$49.9K |
Purchase Sale Sale after option exercise All abbreviations